These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 20722968)

  • 1. The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.
    Thomas DM; Angoa Pérez M; Francescutti-Verbeem DM; Shah MM; Kuhn DM
    J Neurochem; 2010 Nov; 115(3):595-605. PubMed ID: 20722968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH; Angoa-Pérez M; Kuhn DM
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.
    Angoa-Pérez M; Kane MJ; Herrera-Mundo N; Francescutti DM; Kuhn DM
    Life Sci; 2014 Feb; 97(1):31-6. PubMed ID: 23892197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity.
    Thomas DM; Francescutti-Verbeem DM; Kuhn DM
    J Neurochem; 2009 Jun; 109(6):1745-55. PubMed ID: 19457119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.
    Angoa-Pérez M; Kane MJ; Briggs DI; Francescutti DM; Sykes CE; Shah MM; Thomas DM; Kuhn DM
    J Neurochem; 2013 Apr; 125(1):102-10. PubMed ID: 23205838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
    Ramkissoon A; Wells PG
    Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.
    Thomas DM; Walker PD; Benjamins JA; Geddes TJ; Kuhn DM
    J Pharmacol Exp Ther; 2004 Oct; 311(1):1-7. PubMed ID: 15163680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling.
    Thomas DM; Francescutti-Verbeem DM; Kuhn DM
    J Neurochem; 2008 Jul; 106(2):696-705. PubMed ID: 18410508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity.
    Thomas DM; Francescutti-Verbeem DM; Kuhn DM
    J Neurochem; 2008 May; 105(3):605-16. PubMed ID: 18088364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
    Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
    J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of Na(+)/H(+) and Na(+)/Ca(2+) exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity.
    Callahan BT; Cord BJ; Yuan J; McCann UD; Ricaurte GA
    J Neurochem; 2001 Jun; 77(5):1348-62. PubMed ID: 11389186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.
    Fumagalli F; Gainetdinov RR; Valenzano KJ; Caron MG
    J Neurosci; 1998 Jul; 18(13):4861-9. PubMed ID: 9634552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment.
    Gluck MR; Moy LY; Jayatilleke E; Hogan KA; Manzino L; Sonsalla PK
    J Neurochem; 2001 Oct; 79(1):152-60. PubMed ID: 11595767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine.
    Weinshenker D; Ferrucci M; Busceti CL; Biagioni F; Lazzeri G; Liles LC; Lenzi P; Pasquali L; Murri L; Paparelli A; Fornai F
    J Neurochem; 2008 Apr; 105(2):471-83. PubMed ID: 18042179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.
    Nakajima A; Yamada K; Nagai T; Uchiyama T; Miyamoto Y; Mamiya T; He J; Nitta A; Mizuno M; Tran MH; Seto A; Yoshimura M; Kitaichi K; Hasegawa T; Saito K; Yamada Y; Seishima M; Sekikawa K; Kim HC; Nabeshima T
    J Neurosci; 2004 Mar; 24(9):2212-25. PubMed ID: 14999072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity.
    Kuhn DM; Francescutti-Verbeem DM; Thomas DM
    Ann N Y Acad Sci; 2008 Oct; 1139():118-26. PubMed ID: 18991856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity.
    Yuan J; Callahan BT; McCann UD; Ricaurte GA
    J Neurochem; 2001 Jun; 77(5):1338-47. PubMed ID: 11389185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation between hypothermia and neurotoxicity caused by mephedrone and methcathinone in TPH2 knockout mice.
    Anneken JH; Angoa-Perez M; Sati GC; Crich D; Kuhn DM
    Psychopharmacology (Berl); 2019 Mar; 236(3):1097-1106. PubMed ID: 30074064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.
    Zhu JP; Xu W; Angulo JA
    Brain Res; 2005 Jul; 1049(2):171-81. PubMed ID: 16043139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
    Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D
    J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.